A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus · Sponsor: Eli Lilly and Company
About this study
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (635)
| University of Alabama at Birmingham Medical Center | Birmingham, Alabama, United States | — |
| John Muir Medical Center - Concord Campus | Concord, California, United States | — |
| Valley Clinical Trials, Inc. | Covina, California, United States | — |
| AMCR Institute | Escondido, California, United States | — |
| Valley Research | Fresno, California, United States | — |
| NorCal Medical Research, Inc | Greenbrae, California, United States | — |
| UCSD - Altman Clinical and Translational Research Institute (ACTRI) | La Jolla, California, United States | — |
| First Valley Medical Group | Lancaster, California, United States | — |
| Monterey Endocrine & Diabetes Institute, Inc. | Monterey, California, United States | — |
| Riverside University Health System - Medical Center | Moreno Valley, California, United States | — |
| Diabetes Associates Medical Group | Orange, California, United States | — |
| Pasadena Clinical Research | Pasadena, California, United States | — |
+ 623 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04255433